Program Policies & Procedures

This bulletin encourages states to to consider leveraging available Medicaid and Children’s Health Insurance Program (CHIP) opportunities to improve access to mental health (MH) and substance use disorder (SUD) services for individuals experiencing homelessness.

The article reviews how states are using data collected from OUD treatment measures. Emphasis is placed on expanding access to treatment and improving quality and health equity.

SAMHSA's SOAR program increases access to Supplemental Security Income/Social Security Disability Insurance (SSI/SSDI) benefits for eligible individuals who are experiencing or at risk of homelessness and have a serious mental illness and co-occurring substance use disorder.

This page highlights evidence-based services and models that address the complexities of mental illness and addiction, including examples from various states organized by four key frameworks.

Examples on this page illustrate how several different states have taken a comprehensive approach through overall system transformation and/or strategic disruptive investments.

This guide includes best opportunities for driving improvements in opioid stewardship within their organization and community.

This guide helps health care providers, systems, and communities support recovery from substance use disorders via employment mechanisms. 

This web page provides frequently asked questions regarding the 2023 Consolidated Appropriations Act, which eliminates the X-waiver (DATA-Waiver) and increases accessibility of medication-assisted treatment (MAT).

This guidance document provides information regarding issuance of updated DEA registration certificates to reflect Congress’s elimination of the X-waiver (DATA-Waiver) in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).

This letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).